A randomized, double-blind, placebo-controlled study to evaluate sildenafil, ambrisentan combination therapy in pulmonary hypertension, particularly of Eisenmenger syndrome

Pulmonary arterial hypertension (PAH) - a complex and progressive disease that carries significant morbidity and mortality despite optimal medical treatment. Combination therapy for PAH can be more effective than monotherapy. The present randomized trial compared the safety and efficacy of sildenafi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Shaadab, Vijayvergiya, Rajesh, Malhotra, Samir, Rohit, Manoj Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514406/
https://www.ncbi.nlm.nih.gov/pubmed/34627582
http://dx.doi.org/10.1016/j.ihj.2021.07.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514406/
https://www.ncbi.nlm.nih.gov/pubmed/34627582
http://dx.doi.org/10.1016/j.ihj.2021.07.007

Ejemplares similares